Skip to main content
Log in

Molecular docking and structural analysis of cofactor-protein interaction between NAD+ and 11β-hydroxysteroid dehydrogenase type 2

  • Original Paper
  • Published:
Journal of Molecular Modeling Aims and scope Submit manuscript

Abstract

Molecular docking and structural analysis of the cofactor-protein interaction between NAD+ and human (h) or mouse (m) 11β-hydroxysteroid dehydrogenase type 2 (11βHSD2) were performed with the molecular operating environment (MOE). 11βHSD1 (PDB code: 3HFG) was selected as a template for the 3D structure modeling of 11βHSD2. The MOE docking (MOE-dock) and the alpha sphere and excluded volume-based ligand-protein docking (ASE-dock) showed that both NAD+-h11βHSD2 and NAD+-m11βHSD2 models have a similar binding orientation to the template cofactor-protein model. Our present study also revealed that Asp91, Phe94, Tyr232 and Thr267 could be of importance in the interaction between NAD+ and 11βHSD2. NADP+ was incapable of entering into the cofactor-binding site of the 11βHSD2 models. The present study proposes the latest models for 11βHSD2 and its cofactor NAD+, and to the best of our knowledge, this is the first report of a m11βHSD2 model with NAD+.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

Similar content being viewed by others

Abbreviations

11βHSD:

11β-hydroxysteroid dehydrogenase

ASE-dock:

Alpha sphere and excluded volume-based ligand-protein docking

HTS:

High throughput screening

LBS:

Ligand-binding site

MOE:

Molecular operating environment

MOE-dock:

Molecular operating environment docking

VS:

Virtual screening

References

  1. Kurogi Y, Guner OF (2001) Curr Med Chem 8:1035–1055

    CAS  Google Scholar 

  2. Ekins S (2004) Drug Discovery Today 9:276–285

    Article  CAS  Google Scholar 

  3. Jorgensen WL (2004) Science 303:1813–1818

    Article  CAS  Google Scholar 

  4. Bajorath J (2002) Nat Rev Drug Discovery 1:882–894

    Article  CAS  Google Scholar 

  5. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Adv Drug Delivery Rev 23:3–25

    Article  CAS  Google Scholar 

  6. van de Waterbeemd H, Gifford E (2003) Nat Rev Drug Discovery 2:192–204

    Article  Google Scholar 

  7. Lipinski CA (2004) Drug Discovery Today: Technologies 1:337–341

    Article  CAS  Google Scholar 

  8. Shoichet BK (2004) Nature 432:862–865

    Article  CAS  Google Scholar 

  9. Doman TN, McGovern SL, Witherbee BJ, Kasten TP, Kurumbail R, Stallings WC, Connolly DT, Shoichet BK (2002) J Med Chem 45:2213–2221

    Article  CAS  Google Scholar 

  10. Funder JW (2005) Heart Fail Rev 10:15–22

    Article  CAS  Google Scholar 

  11. Hu GX, Lian QQ, Lin H, Latif SA, Morris DJ, Hardy MP, Ge RS (2008) Steroids 73:1018–1024

    Article  CAS  Google Scholar 

  12. Revollo JR, Cidlowski JA (2009) Ann NY Acad Sci 1179:167–178

    Article  CAS  Google Scholar 

  13. Rabbitt EH, Lavery GG, Walker EA, Cooper MS, Stewart PM, Hewison M (2002) FASEB J 16:36–44

    Article  CAS  Google Scholar 

  14. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CR, Seckl JR, Mullins JJ (1997) Proc Natl Acad Sci USA 94:14924–14929

    Article  CAS  Google Scholar 

  15. Holmes MC, Kotelevtsev Y, Mullins JJ, Seckl JR (2001) Mol Cell Endocrinol 171:15–20

    Article  CAS  Google Scholar 

  16. Morton NM, Holmes MC, Fievet C, Staels B, Tailleux A, Mullins JJ, Seckl JR (2001) J Biol Chem 276:41293–41300

    Article  CAS  Google Scholar 

  17. Walker BR, Campbell JC, Williams BC, Edwards CR (1992) Endocrinology 131:970–972

    Article  CAS  Google Scholar 

  18. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS (1994) Mol Cell Endocrinol 105:R11–R17

    Article  CAS  Google Scholar 

  19. Agarwal AK, Mune T, Monder C, White PC (1995) Endocr Res 21:389–397

    Article  CAS  Google Scholar 

  20. Yamaguchi H, Kidachi Y, Kamiie K, Noshita T, Umetsu H, Ryoyama K (2010) Biol Pharm Bull 33:321–324

    Article  CAS  Google Scholar 

  21. Carvajal CA, Gonzalez AA, Romero DG, González A, Mosso LM, Lagos ET, Hevia Mdel P, Rosati MP, Perez-Acle TO, Gomez-Sanchez CE, Montero JA, Fardella CE (2003) J Clin Endocrinol Metab 88:2501–2507

    Article  CAS  Google Scholar 

  22. Koch MA, Wittenberg LO, Basu S, Jeyaraj DA, Gourzoulidou E, Reinecke K, Odermatt A, Waldmann H (2004) Proc Natl Acad Sci USA 101:16721–16726

    Article  CAS  Google Scholar 

  23. Yamaguchi H, Akitaya T, Yu T, Kidachi Y, Kamiie K, Noshita T, Umetsu H, Ryoyama K (2011) Eur J Med Chem 46:1325–1330

    Article  CAS  Google Scholar 

  24. Hosfield DJ, Wu Y, Skene RJ, Hilgers M, Jennings A, Snell GP, Aertgeerts K (2005) J Biol Chem 280:4639–4648

    Article  CAS  Google Scholar 

  25. Ogg D, Elleby B, Norström C, Stefansson K, Abrahmsén L, Oppermann U, Svensson S (2005) J Biol Chem 280:3789–3794

    Article  CAS  Google Scholar 

  26. Wan ZK, Chenail E, Xiang J, Li HQ, Ipek M, Bard J, Svenson K, Mansour TS, Xu X, Tian X, Suri V, Hahm S, Xing Y, Johnson CE, Li X, Qadri A, Panza D, Perreault M, Tobin JF, Saiah E (2009) J Med Chem 52:5449–5461

    Article  CAS  Google Scholar 

  27. Ni XT, Duan T, Yang Z, Guo CM, Li JN, Sun K (2009) Placenta 30:1023–1028

    Article  CAS  Google Scholar 

  28. Huang Y, Li X, Lin H, Chu Y, Chen B, Lian Q, Ge RS (2010) Biochem Biophys Res Commun 391:1752–1756

    Article  CAS  Google Scholar 

  29. Levitt M (1992) J Mol Biol 226:507–533

    Article  CAS  Google Scholar 

  30. Fechteler T, Dengler U, Schomberg D (1995) J Mol Biol 253:114–131

    Article  CAS  Google Scholar 

  31. Liang J, Edelsbrunner H, Fu P, Sudhakar PV, Subramaniam S (1998) Proteins 33:1–17

    Article  CAS  Google Scholar 

  32. Liang J, Edelsbrunner H, Fu P, Sudhakar PV, Subramaniam S (1998) Proteins 33:18–29

    Article  CAS  Google Scholar 

  33. Goto J, Kataoka R, Hirayama N (2004) J Med Chem 47:6804–6811

    Article  CAS  Google Scholar 

  34. Chang DT, Oyang YJ, Lin JH (2005) Nucleic Acids Res 33(suppl 2):W233–W238

    Article  CAS  Google Scholar 

  35. Metropolis N, Ulam S (1949) J Am Stat Assoc 44:335–341

    Article  CAS  Google Scholar 

  36. Metropolis N, Rosenbluth AW, Rosenbluth MN, Teller AH (1953) J Chem Phys 21:1087–1092

    Article  CAS  Google Scholar 

  37. Goto J, Kataoka R, Muta H, Hirayama N (2008) J Chem Inf Model 48:583–590

    Article  CAS  Google Scholar 

  38. Halgren TA (1996) J Comput Chem 17:490–519

    Article  CAS  Google Scholar 

  39. Obeid J, White PC (1992) Biochem Biophys Res Commun 188:222–227

    Article  CAS  Google Scholar 

  40. Oppermann UC, Filling C, Berndt KD, Persson B, Benach J, Ladenstein R, Jornvall H (1997) Biochemistry 36:34–40

    Article  CAS  Google Scholar 

  41. Filling C, Berndt KD, Benach J, Knapp S, Prozorovski T, Nordling E, Ladenstein R, Jornvall H, Oppermann UC (2002) J Biol Chem 277:25677–25684

    Article  CAS  Google Scholar 

  42. Hoffmann F, Maser E (2007) Drug Metab Rev 39:87–144

    Article  CAS  Google Scholar 

  43. Vincent SJF, Zwahlen C, Post CB, Burgner JW, Bodenhausen G (1997) Proc Natl Acad Sci USA 94:4383–4388

    Article  CAS  Google Scholar 

  44. Atanasov AG, Tam S, Rochen JM, Baker ME, Odermatt A (2003) Biochem Biophys Res Commun 308:257–262

    Article  CAS  Google Scholar 

  45. Schuster D, Maurer EM, Laggner C, Nashev LG, Wilckens T, Langer T, Odermatt A (2006) J Med Chem 49:3454–3466

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This study was partially supported by a grant-in-aid from the Promotion and Mutual Aid Corporation for Private Schools of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hideaki Yamaguchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamaguchi, H., Akitaya, T., Yu, T. et al. Molecular docking and structural analysis of cofactor-protein interaction between NAD+ and 11β-hydroxysteroid dehydrogenase type 2. J Mol Model 18, 1037–1048 (2012). https://doi.org/10.1007/s00894-011-1140-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00894-011-1140-2

Keywords

Navigation